ABCL Peer Comparison by Dividends - Abcellera Biologics
ABCL dividend peer comparison: Rates, Yield, Growth, Payouts vs Biotechnology
Compare ABCL Dividends to other Companies
| Symbol | Market Cap | Rate TTM | Yield TTM | Yield On Cost 5Y | CAGR 5Y | Consistency | Payout Ratio | Rating |
|---|---|---|---|---|---|---|---|---|
| ABCL NASDAQ Abcellera Biologics |
1.10B | - | - | - | - | - | - | - |
| ABBV NYSE AbbVie |
411B | 6.56 | 2.86% | 7.80% | 7.06% | 100% | 69.4% | 68.9% |
| AMGN NASDAQ Amgen |
181B | 9.52 | 2.83% | 4.98% | 8.90% | 100% | 43.5% | 67.9% |
| GILD NASDAQ Gilead Sciences |
155B | 3.93 | 3.14% | 7.99% | 3.16% | 100% | 38.3% | 65.5% |
| VRTX NASDAQ Vertex Pharmaceuticals |
110B | - | - | - | - | - | - | - |
| REGN NASDAQ Regeneron Pharmaceuticals |
73.0B | 3.52 | 0.50% | 0.68% | - | 100% | 7.80% | 14.9% |
| ALNY NASDAQ Alnylam Pharmaceuticals |
60.0B | - | - | - | - | - | - | - |
| ARGX NASDAQ argenx |
55.5B | - | - | - | - | - | - | - |
| HLN NYSE Haleon |
44.0B | 0.18 | 1.83% | 2.46% | 51.0% | 100% | 48.2% | 53.3% |
| INSM NASDAQ Insmed |
41.2B | - | - | - | - | - | - | - |
| ONC NASDAQ BeiGene |
38.7B | - | - | - | - | - | - | - |
| NTRA NASDAQ Natera |
27.7B | - | - | - | - | - | - | - |
| 22UA XETRA BioNTech SE |
25.1B | - | - | - | -100% | 1.70% | - | 1.0% |
| BNTX NASDAQ BioNTech SE |
24.7B | - | - | - | -100% | 1.70% | - | 1.0% |
| BIIB NASDAQ Biogen |
24.6B | - | - | - | - | - | - | - |
| UTHR NASDAQ United Therapeutics |
20.1B | - | - | - | - | - | - | - |
| INCY NASDAQ Incyte |
19.9B | - | - | - | - | - | - | - |
| GMAB NASDAQ Genmab AS |
18.8B | - | - | - | - | - | - | - |
| BIM PA Biomerieux |
14.8B | 0.90 | 0.85% | 0.80% | 45.4% | 95.8% | 28.4% | 61.2% |
| NBIX NASDAQ Neurocrine Biosciences |
14.4B | - | - | - | - | - | - | - |
| ROIV NASDAQ Roivant Sciences |
14.3B | - | - | - | - | - | - | - |
| EXAS NASDAQ EXACT Sciences |
13.2B | - | - | - | - | - | - | - |
| ASND NASDAQ Ascendis Pharma AS |
12.6B | - | - | - | - | - | - | - |
| BBIO NASDAQ BridgeBio Pharma |
12.5B | - | - | - | - | - | - | - |
| RVMD NASDAQ Revolution Medicines |
12.4B | - | - | - | - | - | - | - |
| SMMT NASDAQ Summit Therapeutics |
12.3B | - | - | - | - | - | - | - |
| ERF PA Eurofins Scientific SE |
12.2B | 0.60 | 1.05% | 0.93% | -9.74% | 79.2% | 26.4% | 2.79% |
| IONS NASDAQ Ionis Pharmaceuticals |
12.1B | - | - | - | - | 0.80% | - | 0.21% |
| MDGL NASDAQ Madrigal Pharmaceuticals |
12.0B | - | - | - | - | - | - | - |
| EXEL NASDAQ Exelixis |
11.3B | - | - | - | - | - | - | - |
| BMRN NASDAQ Biomarin Pharmaceutical |
10.4B | - | - | - | - | - | - | - |
| MRNA NASDAQ Moderna |
9.75B | - | - | - | - | - | - | - |
| HALO NASDAQ Halozyme Therapeutics |
8.26B | - | - | - | - | - | - | - |
| ABVX NASDAQ Abivax American Depositary |
8.19B | - | - | - | - | - | - | - |
| ABVX PA Abivax |
8.07B | - | - | - | - | - | - | - |
| CYTK NASDAQ Cytokinetics |
8.01B | - | - | - | - | - | - | - |
| GRFS NASDAQ Grifols |
7.65B | 0.17 | 2.05% | 0.97% | 127% | 60.7% | 27.1% | 41.9% |
| MTSR US Metsera, Common Stock |
7.43B | - | - | - | - | - | - | - |
| MRUS NASDAQ Merus BV |
7.29B | - | - | - | - | - | - | - |
| NUVL NASDAQ Nuvalent |
6.89B | - | - | - | - | - | - | - |
| RYTM NASDAQ Rhythm Pharmaceuticals |
6.63B | - | - | - | - | - | - | - |
| RGC NASDAQ Regencell Bioscience |
6.43B | - | - | - | - | - | - | - |
| PTCT NASDAQ PTC Therapeutics |
6.07B | - | - | - | - | - | - | - |
| PCVX NASDAQ Vaxcyte |
5.96B | - | - | - | - | - | - | - |
| KRYS NASDAQ Krystal Biotech |
5.93B | - | - | - | - | - | - | - |
| ARWR NASDAQ Arrowhead Pharmaceuticals |
5.70B | - | - | - | - | - | - | - |
| LEGN NASDAQ Legend Biotech |
5.43B | - | - | - | - | - | - | - |
| PTGX NASDAQ Protagonist Therapeutics |
5.20B | - | - | - | - | - | - | - |
| ACLX NASDAQ Arcellx |
5.20B | - | - | - | - | - | - | - |
| COGT NASDAQ Cogent Biosciences |
5.19B | - | - | - | - | - | - | - |
| TGTX NASDAQ TG Therapeutics |
4.92B | - | - | - | - | - | - | - |
| CRSP NASDAQ Crispr Therapeutics |
4.87B | - | - | - | - | - | - | - |
| ALKS NASDAQ Alkermes |
4.83B | - | - | - | - | - | - | - |
| KYMR NASDAQ Kymera Therapeutics |
4.58B | - | - | - | - | - | - | - |
| PRAX NASDAQ Praxis Precision Medicines |
4.45B | - | - | - | - | - | - | - |
| APGE NASDAQ Apogee Therapeutics, Common |
4.43B | - | - | - | - | - | - | - |
| NAMS NASDAQ NewAmsterdam Pharma |
4.35B | - | - | - | - | - | - | - |
| VKTX NASDAQ Viking Therapeutics |
4.27B | - | - | - | - | - | - | - |
| IMVT NASDAQ Immunovant |
4.16B | - | - | - | - | - | - | - |
| BLTE NASDAQ Belite Bio |
4.08B | - | - | - | - | - | - | - |
| ACAD NASDAQ ACADIA Pharmaceuticals |
4.06B | - | - | - | - | - | - | - |
| CRNX NASDAQ Crinetics Pharmaceuticals |
4.05B | - | - | - | - | - | - | - |
| INDV NASDAQ Indivior Ordinary Shares |
4.03B | - | - | - | - | 10.5% | - | 2.63% |
| CNTA NASDAQ Centessa Pharmaceuticals |
4.03B | - | - | - | - | - | - | - |
| LGND NASDAQ Ligand Pharmaceuticals |
3.96B | - | - | - | - | 0.60% | - | 0.14% |
| ADMA NASDAQ ADMA Biologics |
3.70B | - | - | - | - | - | - | - |
| CELC NASDAQ Celcuity |
3.65B | - | - | - | - | - | - | - |
| SRRK NASDAQ Scholar Rock Holding |
3.60B | - | - | - | - | - | - | - |
| MIRM NASDAQ Mirum Pharmaceuticals |
3.56B | - | - | - | - | - | - | - |
| MLYS NASDAQ Mineralys Therapeutics |
3.51B | - | - | - | - | - | - | - |
| IRON NASDAQ Disc Medicine |
3.40B | - | - | - | - | - | - | - |
| CDTX NASDAQ Cidara Therapeutics |
3.33B | - | - | - | - | - | - | - |
| RARE NASDAQ Ultragenyx |
3.19B | - | - | - | - | - | - | - |
| VCYT NASDAQ Veracyte |
3.15B | - | - | - | - | - | - | - |
| KNSA NASDAQ Kiniksa Pharmaceuticals |
3.13B | - | - | - | - | - | - | - |
| XENE NASDAQ Xenon Pharmaceuticals |
3.09B | - | - | - | - | - | - | - |
| TVTX NASDAQ Travere Therapeutics |
3.03B | - | - | - | - | - | - | - |
| GRAL NASDAQ GRAIL |
3.00B | - | - | - | - | - | - | - |
| DYN NASDAQ Dyne Therapeutics |
2.94B | - | - | - | - | - | - | - |
| IDYA NASDAQ Ideaya Biosciences |
2.90B | - | - | - | - | - | - | - |
| CGON NASDAQ CG Oncology, Common stock |
2.88B | - | - | - | - | - | - | - |
| CPRX NASDAQ Catalyst Pharmaceuticals |
2.83B | - | - | - | - | - | - | - |
| ARQT NASDAQ Arcutis Biotherapeutics |
2.80B | - | - | - | - | - | - | - |
| VRDN NASDAQ Viridian Therapeutics |
2.77B | - | - | - | - | - | - | - |
| DNLI NASDAQ Denali Therapeutics |
2.56B | - | - | - | - | - | - | - |
| AGIO NASDAQ Agios Pharm |
2.55B | - | - | - | - | - | - | - |
| SLNO NASDAQ Soleno Therapeutics |
2.54B | - | - | - | - | - | - | - |
| APLS NASDAQ Apellis Pharmaceuticals |
2.51B | - | - | - | - | - | - | - |
| RCUS NYSE Arcus Biosciences |
2.47B | - | - | - | - | - | - | - |
| ZLAB NASDAQ Zai Lab |
2.46B | - | - | - | - | - | - | - |
| EWTX NASDAQ Edgewise Therapeutics |
2.41B | - | - | - | - | - | - | - |
| FOLD NASDAQ Amicus Therapeutics |
2.35B | - | - | - | - | - | - | - |
| NNNN NASDAQ Anbio Biotechnology |
2.32B | - | - | - | - | - | - | - |
| RXRX NASDAQ Recursion Pharmaceuticals |
2.26B | - | - | - | - | - | - | - |
| BEAM NASDAQ Beam Therapeutics |
2.20B | - | - | - | - | - | - | - |
| GLPG AS Galapagos |
2.18B | - | - | - | - | - | - | - |
| GLPG NASDAQ Galapagos |
2.16B | - | - | - | - | - | - | - |
| GPCR NASDAQ Structure Therapeutics |
2.12B | - | - | - | - | - | - | - |
| IBRX NASDAQ Immunitybio |
2.05B | - | - | - | - | - | - | - |
| AUPH NASDAQ Aurinia Pharmaceuticals |
2.02B | - | - | - | - | - | - | - |
| VCEL NASDAQ Vericel Ord |
2.02B | - | - | - | - | - | - | - |